Follow Us:
Clinical lab
Healthcare Economics

To provide value for all
stakeholders

Read More
Clinical lab
Healthcare Economics

To provide value for all
stakeholders

Read More
Clinical lab
Healthcare Economics

To provide value for all
stakeholders

Read More
Research lab
Business Model

Business Model

Healthcare Economics (HCE) provides consulting services for contract manufacturing, technology transfers, joint ventures, and portfolio management for small and large molecule development and commercialization. These products and services are placed with small, medium and large manufacturers keen to enter and expand within the biotech and pharmaceutical markets. HCE will link FDA and EMA approved manufacturers of both bulk and finished pharmaceuticals with business partners in search of these products to commercialize and capture market share.

Read More
Our Services

Our Services

Product Candidate Acquisition: Early Stage
Healthcare
Product Candidate Acquisition: Early Stage

Contract Development Manufacturing Organizations (CDMO)   and academia are focused on conceptualizing and developing early stage product candidates that will…

Read More
Product Candidate Acquisition: Late Stage
Healthcare
Product Candidate Acquisition: Late Stage

CDMO’s are keen to partner with established biotech & pharmaceutical firms and investment houses are willing to in-license a product…

Read More
Premedia Services
Healthcare
Premedia Services

Healthcare Economics will work with your team to provide assistance for integrated premedia services for pharmaceutical, medical packaging firms, and…

Read More
Preclinical Research Services
Healthcare
Preclinical Research Services

Healthcare Economics partners with firms offering differentiated services in Preclinical Research services in Biology, ADMET-PK, Pharmacology, Exploratory Toxicology and Project…

Read More
Core competencies

Core competencies at Healthcare Economics

IP and Technology Evaluation

HCE has proven experience in technology assessment, valuation and determining pricing for intellectual property.

Strategic Alliances

Many firms are actively seeking partners to develop a strategic alliance whereby each firm agrees on a specific set of objectives and goals to form collaborations.

In-Out Licensing

Many firms will find it compelling and advantageous to in-license or out-license products within various stages of development.

Merger and Acquisition Support

HCE will drive value throughout the deal lifecycle providing strategic merger and acquisition (M&A) and divesture support starting from due diligence, through valuation and culminating in deal closure.

biotechnology and pharmaceutical

Industries

During 2010 -2017 and during 2019-2024 approximately USD $150B and $198B respectively either have been and or are at risk of losing patent protection.

Read More

HCE will utilize its resources in a similar manner as that employed within the biotechnology segment. In many instances pharmaceutical firms are seeking additional

Read More